Bayer (XTRA:BAYN) received FDA Priority Review for KERENDIA for adults with type 1 diabetes and chronic kidney disease. The ...

Bayer has filed to modify the label for its chronic kidney disease (CKD) Kerendia to include people with type 1 diabetes, ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...

(Corrects May 21 story to clarify finerenone is currently used to treat type 2, not type 1 diabetes, in second paragraph) May ...

Medtronic Inc. and Bayer HealthCare, part of Bayer AG, announced Monday that they have expanded an international alliance to now include the U.S. market in a bid to tackle diabetes. Since 2007, the ...

Dance legend and actress Debbie Allen is stepping up for Type 2 diabetes in Bayer’s campaign to raise awareness about its connection to kidney disease. Allen, who was recently diagnosed with ...

China’s Hua Medicine has spent over a decade on one medicine—a diabetes candidate in-licensed from Roche. Now under a partnership with Bayer, the drug has snagged a global first-in-class nod in China.